Search research articles
Contact Us
Filters
Showing results (31-40 of 104) with videos related to
Page
of 11
Sort By:
Indian Journal of Cancer
|
August 28, 2013
Metronomic therapy: chemotherapy revisited
V Noronha, M V Krishna, V Patil, et al.
Indian Journal of Cancer
|
September 25, 2013
Presentation, complications, and impact of concurrent malaria infection on anticancer therapy
V Noronha, G Goyal, A Joshi, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
May 9, 2006
Surgical reconstruction of attempted suicide charcoal burns
Andrew Burd, Kawser Ahmed, Frederick V Noronha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 24, 2019
NUT Midline Carcinoma
V M Patil, A Toshniwal, V Noronha, et al.
Indian Journal of Cancer
|
May 6, 2016
Cisplatin based adjuvant chemoradiation following neoadjuvant chemotherapy and surgery in advanced oral cavity cancers: A deliverable regimen?
V Noronha, A Joshi, V Patil, et al.
Indian Journal of Cancer
|
May 8, 2010
Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern
K Prabhash, A Medhekar, N Ghadyalpatil, et al.
Indian Journal of Cancer
|
March 11, 2016
Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers
V Patil, A Karpe, V Noronha, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health
|
June 4, 1999
[Violence, ethnic groups and skin color: a study on differences in the metropolitan region of Salvador, Bahia, Brazil]
C V Noronha, E P Machado, G Tapparelli, et al.
Indian Journal of Cancer
|
December 11, 2014
Oral cutaneous leishmaniasis mimicking carcinoma of tongue: A case report
A Joshi, S B Dhumal, V Noronha, et al.
Indian Journal of Cancer
|
December 5, 2017
Development and validation of a predictive score, for identifying poor eastern cooperative oncology group performance status (performance status 3-4) advanced nonsmall cell lung cancer patients who are likely to benefit from tyrosine kinase inhibitors
A Joshi, A Bhattacharjee, V Noronha, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 104) with videos related to
Sort By:
Page
of 11
Indian Journal of Cancer
|
August 28, 2013
Metronomic therapy: chemotherapy revisited
V Noronha, M V Krishna, V Patil, et al.
Indian Journal of Cancer
|
September 25, 2013
Presentation, complications, and impact of concurrent malaria infection on anticancer therapy
V Noronha, G Goyal, A Joshi, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
May 9, 2006
Surgical reconstruction of attempted suicide charcoal burns
Andrew Burd, Kawser Ahmed, Frederick V Noronha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 24, 2019
NUT Midline Carcinoma
V M Patil, A Toshniwal, V Noronha, et al.
Indian Journal of Cancer
|
May 6, 2016
Cisplatin based adjuvant chemoradiation following neoadjuvant chemotherapy and surgery in advanced oral cavity cancers: A deliverable regimen?
V Noronha, A Joshi, V Patil, et al.
Indian Journal of Cancer
|
May 8, 2010
Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern
K Prabhash, A Medhekar, N Ghadyalpatil, et al.
Indian Journal of Cancer
|
March 11, 2016
Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers
V Patil, A Karpe, V Noronha, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health
|
June 4, 1999
[Violence, ethnic groups and skin color: a study on differences in the metropolitan region of Salvador, Bahia, Brazil]
C V Noronha, E P Machado, G Tapparelli, et al.
Indian Journal of Cancer
|
December 11, 2014
Oral cutaneous leishmaniasis mimicking carcinoma of tongue: A case report
A Joshi, S B Dhumal, V Noronha, et al.
Indian Journal of Cancer
|
December 5, 2017
Development and validation of a predictive score, for identifying poor eastern cooperative oncology group performance status (performance status 3-4) advanced nonsmall cell lung cancer patients who are likely to benefit from tyrosine kinase inhibitors
A Joshi, A Bhattacharjee, V Noronha, et al.
Page
of 11